The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.

by MacNeill, F. A., Jones, A. L., Jacobs, S., Lønning, P. E., Powles, T. J., Dowsett, M.
Published 1992

Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.

by MacNeill, F. A., Jacobs, S., Lønning, P. E., Powles, T. J., Dowsett, M.
Published 1994

99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.

by Biassoni, L., Granowska, M., Carroll, M. J., Mather, S. J., Howell, R., Ellison, D., MacNeill, F. A., Wells, C. A., Carpenter, R., Britton, K. E.
Published 1998

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients...

by Dowsett, M., MacNeill, F., Mehta, A., Newton, C., Haynes, B., Jones, A., Jarman, M., Lonning, P., Powles, T. J., Coombes, R. C.
Published 1991